130 related articles for article (PubMed ID: 21185599)
1. Splenic infarction associated with rapidly progressive chronic lymphocytic leukemia with complex karyotype and ATM mutation.
Dyer MJ; Majid A; Walewska R; Gesk S; Harder L; Siebert R; Morgan B
Leuk Res; 2011 May; 35(5):e55-7. PubMed ID: 21185599
[No Abstract] [Full Text] [Related]
2. [Gene atm and chronic lymphocytic leukemia - review].
Zhu DX; Xu W; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1242-6. PubMed ID: 18928637
[TBL] [Abstract][Full Text] [Related]
3. ATM and chronic lymphocytic leukemia: mutations, and not only deletions, matter.
Rossi D; Gaidano G
Haematologica; 2012 Jan; 97(1):5-8. PubMed ID: 22210328
[No Abstract] [Full Text] [Related]
4. ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele.
Skowronska A; Austen B; Powell JE; Weston V; Oscier DG; Dyer MJ; Matutes E; Pratt G; Fegan C; Moss P; Taylor MA; Stankovic T
Haematologica; 2012 Jan; 97(1):142-6. PubMed ID: 21933854
[TBL] [Abstract][Full Text] [Related]
5. Imperfect correlation between p53 dysfunction and deletion of TP53 and ATM in chronic lymphocytic leukaemia.
Carter A; Lin K; Sherrington PD; Atherton M; Pearson K; Douglas A; Burford A; Brito-Babapulle V; Matutes E; Catovsky D; Pettitt AR
Leukemia; 2006 Apr; 20(4):737-40. PubMed ID: 16437137
[No Abstract] [Full Text] [Related]
6. No evidence for DNA methylation of the ATM promoter CpG island in chronic lymphocytic leukemia.
Mikeska T; Carney DA; Seymour JF; Dobrovic A
Leuk Lymphoma; 2012 Jul; 53(7):1420-2. PubMed ID: 22204453
[No Abstract] [Full Text] [Related]
7. Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study.
Lozanski G; Ruppert AS; Heerema NA; Lozanski A; Lucas DM; Gordon A; Gribben JG; Morrison VA; Rai KM; Marcucci G; Larson RA; Byrd JC
Leuk Lymphoma; 2012 Sep; 53(9):1743-8. PubMed ID: 22369572
[TBL] [Abstract][Full Text] [Related]
8. ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression.
Guarini A; Marinelli M; Tavolaro S; Bellacchio E; Magliozzi M; Chiaretti S; De Propris MS; Peragine N; Santangelo S; Paoloni F; Nanni M; Del Giudice I; Mauro FR; Torrente I; Foà R
Haematologica; 2012 Jan; 97(1):47-55. PubMed ID: 21993670
[TBL] [Abstract][Full Text] [Related]
9. Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial.
Skowronska A; Parker A; Ahmed G; Oldreive C; Davis Z; Richards S; Dyer M; Matutes E; Gonzalez D; Taylor AM; Moss P; Thomas P; Oscier D; Stankovic T
J Clin Oncol; 2012 Dec; 30(36):4524-32. PubMed ID: 23091097
[TBL] [Abstract][Full Text] [Related]
10. Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stage.
Britt-Compton B; Lin TT; Ahmed G; Weston V; Jones RE; Fegan C; Oscier DG; Stankovic T; Pepper C; Baird DM
Leukemia; 2012 Apr; 26(4):826-30. PubMed ID: 21986843
[No Abstract] [Full Text] [Related]
11. Incidence and clinical implications of ATM aberrations in chronic lymphocytic leukemia.
Ouillette P; Li J; Shaknovich R; Li Y; Melnick A; Shedden K; Malek SN
Genes Chromosomes Cancer; 2012 Dec; 51(12):1125-32. PubMed ID: 22952040
[TBL] [Abstract][Full Text] [Related]
12. New translocations in a case of atypical B-cell chronic lymphocytic leukemia: involvement of ATM, MLL, and TP53 genes.
Collado R; Hueso J; Cabello AI; Oliver I; Egea M; Orero M; Miguel-Sosa A; Cigudosa JC; Benítez J; Barragán E; Carbonell F
Cancer Genet Cytogenet; 2006 Sep; 169(2):176-8. PubMed ID: 16938579
[No Abstract] [Full Text] [Related]
13. A novel functional assay using etoposide plus nutlin-3a detects and distinguishes between ATM and TP53 mutations in CLL.
Best OG; Gardiner AC; Majid A; Walewska R; Austen B; Skowronska A; Ibbotson R; Stankovic T; Dyer MJ; Oscier DG
Leukemia; 2008 Jul; 22(7):1456-9. PubMed ID: 18200038
[No Abstract] [Full Text] [Related]
14. Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion.
Austen B; Skowronska A; Baker C; Powell JE; Gardiner A; Oscier D; Majid A; Dyer M; Siebert R; Taylor AM; Moss PA; Stankovic T
J Clin Oncol; 2007 Dec; 25(34):5448-57. PubMed ID: 17968022
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL.
Austen B; Powell JE; Alvi A; Edwards I; Hooper L; Starczynski J; Taylor AM; Fegan C; Moss P; Stankovic T
Blood; 2005 Nov; 106(9):3175-82. PubMed ID: 16014569
[TBL] [Abstract][Full Text] [Related]
16. A unique lethal blastoid transformation of B-cell chronic lymphocytic leukemia carrying ATM/11q deletion and trisomy 12.
Lu Y; Huang Q
Leuk Res; 2009 Aug; 33(8):e124-6. PubMed ID: 19269030
[No Abstract] [Full Text] [Related]
17. Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia.
Ripollés L; Ortega M; Ortuño F; González A; Losada J; Ojanguren J; Soler JA; Bergua J; Coll MD; Caballín MR
Cancer Genet Cytogenet; 2006 Nov; 171(1):57-64. PubMed ID: 17074592
[TBL] [Abstract][Full Text] [Related]
18. ATM mutations and protein expression are not associated with familial B-CLL cases.
Ishibe N; Goldin LR; Caporaso NE; Sgambati MT; Dean M; Albitar M; Manshouri T; Gerrard B; Marti GE
Leuk Res; 2003 Oct; 27(10):973-5. PubMed ID: 12860021
[No Abstract] [Full Text] [Related]
19. Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage.
Stankovic T; Stewart GS; Fegan C; Biggs P; Last J; Byrd PJ; Keenan RD; Moss PA; Taylor AM
Blood; 2002 Jan; 99(1):300-9. PubMed ID: 11756185
[TBL] [Abstract][Full Text] [Related]
20. Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters.
Haferlach C; Dicker F; Weiss T; Schnittger S; Beck C; Grote-Metke A; Oruzio D; Kern W; Haferlach T
Genes Chromosomes Cancer; 2010 Sep; 49(9):851-9. PubMed ID: 20552631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
